Table 3.
Plasma fatty acid composition and product to substrate ratios in the third trimester by maternal alcohol exposure and FASD classification controlled for maternal smoking.
| Controls | AE-ND | AE-FASD | Sig | Controls | AE-ND | AE-FASD | Sig | ||
|---|---|---|---|---|---|---|---|---|---|
| N=46 | N=32 | N=29 | N=46 | N=32 | N=30 | ||||
| Saturated | Desaturation | ||||||||
| C14:0 | 1.09±0.07 | 0.97±0.09 | 1.04±0.09 | 0.633 | 16:1n7/16:0 | 0.05±0.00 | 0.05±0.00 | 0.05±0.00 | 0.614 |
| C16:0 | 25.93±0.39 | 25.02±0.47 | 26.26±0.50 | 0.197 | 18:1n9/18:0 | 3.03±0.07a,b | 3.26±0.09a | 2.80±0.10b | 0.005 |
| C18:0 | 6.16±0.11a | 6.20±0.14b | 6.91±0.15b | <0.001 | 18:3n6/18:2n6 | 0.005±0.00 | 0.004±0.00 | 0.005±0.01 | 0.039 |
| C20:0 | 0.12±0.01 | 0.12±0.01 | 0.13±0.01 | 0.604 | 20:4n6/20:3n6 | 3.01±0.18a | 3.45±0.22a | 4.34±0.23b | <0.001 |
| C22:0 | 0.19±0.01 | 0.20±0.01 | 0.21±0.01 | 0.487 | Elongation | ||||
| C24:0 | 0.16±0.01 | 0.15±0.01 | 0.15±0.01 | 0.714 | 18:0/16:0 | 0.24±0.01 | 0.25±0.01 | 0.27±0.01 | 0.067 |
| Monounsaturated | 22:4n6/20:4n6 | 0.053±0.00a | 0.044±0.00b | 0.045±0.00a,b | 0.021 | ||||
| C16:1n7 | 1.36±0.09 | 1.20±0.11 | 1.40±0.12 | 0.442 | 22:5n3/20:5n3 | 1.49±0.11 | 1.27±0.13 | 1.41±0.14 | 0.459 |
| C18:1n9 | 18.44±0.37 | 19.89±0.46 | 19.11±0.49 | 0.061 | Fatty Acid Ratios | ||||
| C20:1n9 | 0.21±0.01a | 0.26±0.01b | 0.21±0.01a,b | 0.028 | 16:0/18:2n6 | 0.78±0.03 | 0.73±0.03 | 0.83±0.04 | 0.140 |
| C24:1n9 | 0.26±0.02 | 0.21±0.03 | 0.22±0.03 | 0.433 | 18:2n6/18:3n3 | 190.15±11.76 | 181.96±14.46 | 190.90±15.48 | 0.894 |
| Omega-6 | 20:4n6/20:5n3 | 32.29±3.37 | 26.77±4.14 | 39.93±4.43 | 0.122 | ||||
| C18:2n6 | 34.68±0.71 | 35.06±0.87 | 32.60±0.93 | 0.141 | 22:5n6/22:6n3 | 0.11±0.01a | 0.09±0.01a | 0.17±0.02b | 0.002 |
| C18:3n6 | 0.16±0.01a | 0.13±0.01b | 0.15±0.01a,b | 0.034 | 22:5n6/22:4n6 | 0.82±0.04a | 0.82±0.05a | 1.15±0.05b | <0.001 |
| C20:2n6 | 0.44±0.03 | 0.39±0.03 | 0.35±0.03 | 0.109 | 22:6n3/22:5n3 | 8.48±0.30 | 7.84±0.37 | 8.59±0.40 | 0.333 |
| C20:3n6 | 1.63±0.07a | 1.41±0.09a,b | 1.29±0.10b | 0.022 | Omega 6:Omega 3 | 17.38±0.89 | 16.98±1.09 | 17.99±1.17 | 0.833 |
| C20:4n6 | 4.59±0.16a | 4.50±0.20a | 5.30±0.21b | 0.017 | |||||
| C22:4n6 | 0.24±0.01a | 0.20±0.01b | 0.23±0.01a,b | 0.024 | |||||
| C22:5n6 | 0.20±0.01a | 0.16±0.02a | 0.27±0.02b | 0.001 | |||||
| Omega-3 | |||||||||
| C18:3n3 | 0.22±0.01 | 0.21±0.02 | 0.19±0.02 | 0.637 | |||||
| C20:5n3 | 0.21±0.04 | 0.32±0.05 | 0.27±0.05 | 0.250 | |||||
| C22:5n3 | 0.24±0.01 | 0.26±0.02 | 0.22±0.02 | 0.380 | |||||
| C22:6n3 | 1.95±0.09 | 1.99±0.11 | 1.85±0.12 | 0.717 | |||||
| Total Fatty Acids (μg/ml) | 4753.96±147.06 | 4685.80±180.76 | 4419.61±193.49 | 0.411 |
Estimated marginal means ± standard error of mean (SEM) by general linear model. Individual plasma fatty acids are presented as a percent of total fatty acids. Means in a row with different superscript letters differ with a p-value < 0.05. Models were adjusted for SES, site, pre-pregnancy BMI, cigarettes smoked per day at enrollment, and gestational age at blood draw. One subject in the AE-ND group had a missing variable for pre-pregnancy BMI and one subject in the AE-FASD group had a missing variable for SES thus were not included in this analysis.